Literature DB >> 12005436

Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter.

Carlos R Escalante1, Leyi Shen, Dimitris Thanos, Aneel K Aggarwal.   

Abstract

Upon viral infection, NF-kappaB translocates to the nucleus and activates the IFN-beta gene by binding to the PRDII element. Strikingly, NF-kappaB loses its ability to activate the IFN-beta gene when the PRDII element is substituted by closely related sites. We report here the crystal structure of NF-kappaB p50/p65 heterodimer bound to the PRDII element from the IFN-beta promoter. The structure reveals an unexpected alteration in configuration, in which the p50 specificity domain moves by as much as approximately 9 A when compared to NF-kappaB heterodimer bound to the immunoglobulin kappaB site (Ig-kappaB) while maintaining the same base-specific contacts with the DNA. Taken together, the structure offers new insights into the allosteric effects of closely related DNA sites on the configuration of NF-kappaB and its transcriptional selectivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005436     DOI: 10.1016/s0969-2126(02)00723-2

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  28 in total

1.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  The N terminus of adenovirus type 12 E1A inhibits major histocompatibility complex class I expression by preventing phosphorylation of NF-kappaB p65 Ser276 through direct binding.

Authors:  Junfang Jiao; Hancheng Guan; Andrew M Lippa; Robert P Ricciardi
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 3.  Transcriptional and chromatin regulation in interferon and innate antiviral gene expression.

Authors:  Nancy Au-Yeung; Curt M Horvath
Journal:  Cytokine Growth Factor Rev       Date:  2018-10-22       Impact factor: 7.638

4.  Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

Authors:  Wei-Choong Ch'ng; Noraini Abd-Aziz; Meng-Hua Ong; Eric J Stanbridge; Norazizah Shafee
Journal:  Cell Oncol (Dordr)       Date:  2015-05-01       Impact factor: 6.730

5.  A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.

Authors:  Kristina Bečanović; Anne Nørremølle; Scott J Neal; Chris Kay; Jennifer A Collins; David Arenillas; Tobias Lilja; Giulia Gaudenzi; Shiana Manoharan; Crystal N Doty; Jessalyn Beck; Nayana Lahiri; Elodie Portales-Casamar; Simon C Warby; Colúm Connolly; Rebecca A G De Souza; Sarah J Tabrizi; Ola Hermanson; Douglas R Langbehn; Michael R Hayden; Wyeth W Wasserman; Blair R Leavitt
Journal:  Nat Neurosci       Date:  2015-05-04       Impact factor: 24.884

Review 6.  A structural guide to proteins of the NF-kappaB signaling module.

Authors:  Tom Huxford; Gourisankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

7.  Interferons direct an effective innate response to Legionella pneumophila infection.

Authors:  Courtney R Plumlee; Carolyn Lee; Amer A Beg; Thomas Decker; Howard A Shuman; Christian Schindler
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

8.  Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNFα/NF-κB response.

Authors:  Anja Reintjes; Julian E Fuchs; Leopold Kremser; Herbert H Lindner; Klaus R Liedl; Lukas A Huber; Taras Valovka
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-05       Impact factor: 11.205

9.  An atomic model of the interferon-beta enhanceosome.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

10.  Tumorigenic adenovirus type 12 E1A inhibits phosphorylation of NF-kappaB by PKAc, causing loss of DNA binding and transactivation.

Authors:  Hancheng Guan; Junfang Jiao; Robert P Ricciardi
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.